CME Group operates as a global markets company, providing trading and clearing services across various asset classes, including derivatives, options, and futures. Its core products encompass commodities, financials, and equity indices. Major business segments include the CME, CBOT, NYMEX, and COMEX exchanges. The primary revenue sources are transaction fees, market data services, and clearing services, driven by trading volumes and market activity.
The investment profile of CME Group is characterized by a balanced approach, appealing to investors seeking both growth and income through dividends. The company offers a competitive dividend yield, alongside potential for capital appreciation driven by market activity. This profile suits investors with a medium to long-term horizon, looking for stability and moderate risk.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-07-25 | Hold | Buy | Solid fundamentals, but mixed momentum signals present risks. |
| 2026-07-21 | Sell | Hold | Strong fundamentals, but negative momentum raises concerns. |
| 2026-07-11 | Hold | Sell | Mixed performance; cautious outlook amid market volatility. |
| 2026-07-03 | Sell | Hold | Mixed performance; cautious outlook amid market volatility. |
| 2026-06-25 | Hold | Sell | Weak momentum and high risk overshadow fundamentals. |
| 2026-06-17 | Buy | Hold | Weak momentum and high risk; cautious approach advised. |
| 2026-06-11 | Sell | Buy | Mixed momentum; solid fundamentals but recent volatility. |
| 2026-05-28 | Hold | Sell | Weak momentum and high risk outweigh dividend yield benefits. |
| 2026-05-24 | Buy | Hold | Solid fundamentals, but mixed momentum signals present risks. |
| 2026-05-16 | Hold | Buy | Strong fundamentals and positive recent performance support growth. |
| 2026-05-08 | — | Hold | Weak momentum and high risk offset solid fundamentals. |
| 2026-05-08 | Buy | Buy | Компания показывает стабильный рост выручки и дивидендную доходность, однако недавние колебания цен и снижение на более длительных временных интервалах вызывают осторожность. |
| 2026-01-30 | Hold | Buy | Компания демонстрирует положительную динамику роста цен на акции за последние 60 дней, что указывает на сильный интерес инвесторов. Несмотря на отсутствие данных по EPS и дивидендам, общий тренд и momentum поддерживают п |
| 2026-01-29 | Buy | Hold | Компания демонстрирует стабильный рост за последние 60 дней, однако отсутствие данных по EPS и дивидендам вызывает некоторые сомнения в её финансовой устойчивости. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-07-23 | Morgan Stanley | Target Raised | 324 → 330 | 252.8 |
| 2026-07-15 | Piper Sandler | Target Lowered | 329 → 295 | 243.61 |
| 2026-07-10 | Morgan Stanley | Target Lowered | 353 → 324 | 237.4599 |
| 2026-07-06 | UBS | Target Lowered | 310 → 260 | 236.6 |
| 2026-06-17 | Piper Sandler | Update | — → 320 | 248.12 |
| 2026-06-15 | Piper Sandler | Update | — → 329 | 267.85 |
| 2026-06-11 | Redburn Partners | Rating Upgraded | — → 323 | 263.8 |
| 2026-04-23 | Morgan Stanley | Target Lowered | 362 → 353 | 282.445 |
| 2026-04-23 | Barclays | Target Lowered | 343 → 316 | 285.71 |
| 2026-04-10 | Morgan Stanley | Target Raised | 340 → 362 | 294.815 |
| 2026-02-06 | UBS | Target Raised | 280 → 310 | 297.38 |
| 2026-02-05 | RBC Capital | Target Raised | 295 → 302 | 300.415 |
| 2026-02-05 | Morgan Stanley | Target Raised | 319 → 340 | 294.62 |
| 2026-02-05 | Barclays | Target Raised | 304 → 312 | 294.62 |
| 2026-01-15 | Morgan Stanley | Target Lowered | 320 → 319 | 273.4137 |
| 2025-12-22 | Morgan Stanley | Target Raised | 314 → 320 | 269.09 |
| 2025-12-12 | Barclays | Target Raised | 280 → 304 | 272.42 |
